Skip to Content
Merck
  • Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors.

Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors.

Development (Cambridge, England) (2014-12-18)
Dimitris Karamitros, Alexandra L Patmanidi, Panoraia Kotantaki, Alexandre J Potocnik, Tomi Bähr-Ivacevic, Vladimir Benes, Zoi Lygerou, Dimitris Kioussis, Stavros Taraviras
ABSTRACT

Balancing stem cell self-renewal and initiation of lineage specification programs is essential for the development and homeostasis of the hematopoietic system. We have specifically ablated geminin in the developing murine hematopoietic system and observed profound defects in the generation of mature blood cells, leading to embryonic lethality. Hematopoietic stem cells (HSCs) accumulated in the fetal liver following geminin ablation, while committed progenitors were reduced. Genome-wide transcriptome analysis identified key HSC transcription factors as being upregulated upon geminin deletion, revealing a gene network linked with geminin that controls fetal hematopoiesis. In order to obtain mechanistic insight into the ability of geminin to regulate transcription, we examined Hoxa9 as an example of a key gene in definitive hematopoiesis. We demonstrate that in human K562 cells geminin is associated with HOXA9 regulatory elements and its absence increases HOXA9 transcription similarly to that observed in vivo. Moreover, silencing geminin reduced recruitment of the PRC2 component SUZ12 to the HOXA9 locus and resulted in an increase in RNA polymerase II recruitment and H3K4 trimethylation (H3K4me3), whereas the repressive marks H3K9me3 and H3K27me3 were reduced. The chromatin landscape was also modified at the regulatory regions of HOXA10 and GATA1. K562 cells showed a reduced ability to differentiate to erythrocytes and megakaryocytes upon geminin silencing. Our data suggest that geminin is indispensable for fetal hematopoiesis and regulates the generation of a physiological pool of stem and progenitor cells in the fetal hematopoietic system.

MATERIALS
Product Number
Brand
Product Description

Supelco
Aphidicolin, analytical standard
Sigma-Aldrich
Cytidine 5′-monophosphate, Sigma Grade, ≥99% (HPLC), synthetic, powder
Sigma-Aldrich
Sodium azide, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Sodium azide, BioXtra
Sigma-Aldrich
Aphidicolin from Nigrospora sphaerica, ≥98% (HPLC), powder
Sigma-Aldrich
Sodium azide, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Sodium azide, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Anti-SUZ12 Antibody, clone 2AO9, clone 2AO9, from mouse